Optofluidics, Inc.

Optofluidics, Inc. specializes in optofluidic technology for biotech applications, developing single-cell functional analysis platforms such as the Beacon series instruments (Beacon, Beacon Quest, Beacon Select). These platforms utilize OptoSelect chips with NanoPens and photonic resonator technology. Their tools support various applications including molecular trapping, disease diagnosis, immune profiling, cell therapy, antibody discovery, and cell line development. Launched from Cornell University in 2011, the company primarily focuses on providing research tools rather than developing therapeutic pipelines. A distinct entity, Optofluidics Bioassay (founded 2015), developed microfluidic ELISA plates.